FDA advisory panel rejects COVID-19 booster shots for most Americans By Shen Wu Tan - The Washington Times Shares
Biden careful not to play favorites, but Pfizer enjoys some ‘comparative advantage’ in mandate era By Tom Howell Jr. - The Washington Times Shares
Crunch time for Biden’s booster plan as key health panels convene By Tom Howell Jr. - The Washington Times Shares
FDA official hopeful younger kids can get shots this year By Lauran Neergaard - Associated Press Shares
FDA rejects almost 1 million flavored e-cigarette, vaping products, orders removed from market By Shen Wu Tan - The Washington Times Shares
Health officials: Choose safer COVID options than ivermectin By Dave Kolpack - Associated Press Shares
Fauci optimistic about Pfizer booster shot approval by Sept. 20 By Seth McLaughlin - The Washington Times Shares
Dr. Fauci: Three-dose program could become standard for COVID-19 vaccine By Tom Howell Jr. - The Washington Times Shares
Rep. Louis Gohmert touts ivermectin as COVID-19 treatment contrary to warnings from CDC, FDA By Andrew Blake - The Washington Times Shares
Get the shot or else: Corporate America, health companies put teeth behind vaccine mandates By Tom Howell Jr. - The Washington Times Shares
Pentagon orders COVID-19 vaccinations for military personnel By Mike Glenn - The Washington Times Shares
Pentagon: U.S. troops must get their COVID-19 vaccines ASAP By Lolita C. Baldor - Associated Press Shares
Pfizer vaccine’s FDA approval creates new hurdle for anti-mandate lawsuits By Alex Swoyer - The Washington Times Shares
FDA fully approves Pfizer-BioNTech COVID-19 shot; major step should spur vaccinations, mandates By Tom Howell Jr. - The Washington Times Shares
Biden: More employers should mandate COVID-19 vaccination By Tom Howell Jr. - The Washington Times Shares
Mandates begin in earnest after full FDA approval of Pfizer vaccine By Tom Howell Jr. - The Washington Times Shares
COVID-19 mandates wade into uncertain legal territory By Tom Howell Jr. - The Washington Times Shares
FDA prioritizing review for Pfizer-BioNTech COVID-19 vaccine approval, companies say By Shen Wu Tan - The Washington Times Shares
U.S. health officials expected to add new warning to J&J COVID vaccine By Shen Wu Tan - The Washington Times Shares